
Awakn Life Sciences: Expanding and Finalizing Private Placement Financing
Awakn Life Sciences Corp. Announces Increase in Financing and Closing of Fourth Tranche Introduction Toronto, Ontario–(Newsfile Corp. – September 18, 2024) – Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”) a clinical-stage biotechnology company developing therapeutics for substance use and mental health disorders, with a near-term focus on Alcohol…